Acadia Healthcare Q3 net loss $217.7M on $394M legal charges; revenue up 12.5%

Acadia Healthcare Company, Inc.

2023-Q3 EPS reported -$0.87 revenue$2,185,938,000

Revenue $750.3M, +12.5% YoY; same facility revenue +13.0%.
Net loss $217.7M ($2.39 diluted EPS) from $394.2M legal settlement expense.
Adjusted income $83.9M ($0.91 diluted EPS); Adj. EBITDA $175.9M (+13.4%).
Opened two new hospitals with JV partners and two comprehensive treatment centers in Q3.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Acadia Healthcare Company, Inc. reported the third quarter ended September 30, 2023 results: revenue $750.3 million, net income $217.7 million, EPS $2.39 per diluted share.

Period: the third quarter ended September 30, 2023
Revenue: $750.3 million
Net income: $217.7 million
EPS: $2.39 per diluted share
Result: reported results

Exact text from the filing

Acadia Healthcare Company, Inc. (“Acadia”) (NASDAQ: ACHC) today announced financial results for the third quarter ended September 30, 2023. Third Quarter Highlights Revenue totaled $750.3 million

View on SEC.gov

Browse all earnings releases →

Acadia Healthcare Company, Inc. filing history →

Source: SEC EDGAR

accession 0001157523-23-001637

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.